Product Image

Brain Cell Support

Metabolic Maintenance
4.8
★ ★ ★ ★ ★
(527 ratings)
Acetyl L-Carnitine 500 mg
Ginkgo
Deanol 100 mg
Product Image
Score75
Well-chosen cognitive actives and clear doses create a strong multi-pathway formula. High cost and meaningful interaction concerns keep it from being a simple everyday choice.
How scoring works
Quantity:60 Capsule(s) • (30 servings)
Goals:
Mental Focus
Brain Health
Cognitive Support
Productivity Boost
Anti-Aging
Energy
Metabolism Boost

Score 75

Well-chosen cognitive actives and clear doses create a strong multi-pathway formula. High cost and meaningful interaction concerns keep it from being a simple everyday choice.
How scoring works
$57.60($1.92 per serving)
Pure Formulas
$ 68.00
iHerb
$ 68.00
Amazon
$ 57.60
iHerb
$ 68.00
Report prices

Analysis

The two-capsule serving provides 500 mg of acetyl-L-carnitine, 200 mg of Cognizin citicoline, and 100 mg each of DMAE and sunflower phosphatidylserine. Ginkgo and gotu kola add circulation and botanical pathways to a strong membrane and acetylcholine foundation.

Most amounts are clearly stated and several sit in useful supporting ranges. Ginkgo markers are named without percentages, while the acetyl-L-carnitine salt and DMAE active yield are not fully specified.

Two capsules are practical, but the serving cost is high. The formula best fits users who value a broad cognitive stack enough to accept the price and who can screen bleeding and cholinergic medication interactions.

Who is it for
  • Adults seeking a premium broad cognitive stack
  • Users who want branded citicoline with acetyl-L-carnitine
  • People able to review medication interactions
Best for
  • Memory and focus support
  • Combining citicoline with phosphatidylserine
  • A two-capsule multi-pathway routine

Pros

  • Uses Cognizin citicoline
  • Provides a useful acetyl-L-carnitine amount
  • Includes sunflower phosphatidylserine
  • Adds ginkgo, DMAE, and gotu kola
  • Clearly states most ingredient amounts

Cons

  • Serving cost is high
  • Ginkgo marker percentages are missing
  • DMAE active yield is unclear
  • Acetyl-L-carnitine salt is not specified
  • The stack has a meaningful interaction burden

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.
  • DMAE and citicoline may add cholinergic effects such as headache, nausea, restlessness, or insomnia.
  • Take the formula earlier in the day if its cholinergic ingredients disrupt sleep.

Nutrient quality

87 Highest impact

Cognizin citicoline, sunflower phosphatidylserine, and standardized botanical extracts are well-specified forms. The main cognitive ingredients have useful amounts, with no central ingredient appearing merely decorative.

Ingredient transparency

72 High impact

Every listed active has a specific amount. Capsule materials and other inactive ingredients are not shown.

Customer satisfaction

65 Moderate impact

The supplied aggregate rating indicates very favorable satisfaction, though no experience details are provided. No specific feedback is supplied, so recurring complaints cannot be assessed.

Value for money

74 High impact

The premium cost is supported by a focused set of branded and standardized cognitive ingredients. The serving cost is high despite the generally well-built formula.

Report analysis

Goals

Mental Focus
Mental Focus
Impact
Highest effect
A Goal FitA Strength of SupportA CoverageA Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl L-carnitine, Cognizin citicoline, phosphatidylserine, ginkgo, and supportive botanicals cover several major focus pathways. The strongest actives have useful human evidence for brain energy, acetylcholine production, membrane function, and circulation.

Core ingredients are individually disclosed at purposeful amounts, with branded citicoline adding form quality. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, especially around surgery.

Study evidence
Acetyl L-Carnitine Supportive 7 studies
Ginkgo Supportive 28 studies
Brain Health
Brain Health
Impact
Highest effect
A Goal FitA- Strength of SupportA CoverageA- Formula Quality

Acetyl L-carnitine, Cognizin citicoline, phosphatidylserine, and ginkgo create broad support for brain energy, acetylcholine, membranes, and circulation. Most major ingredients reach practical standalone amounts.

Branded citicoline and sunflower phosphatidylserine strengthen form quality, while ginkgo and gotu kola lack complete marker percentages. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Ginkgo Supportive 90 studies
Cognitive Support
Cognitive Support
Impact
Highest effect
A Goal FitA- Strength of SupportA CoverageA- Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl L-carnitine, Cognizin citicoline, phosphatidylserine, and ginkgo create broad support for brain energy, acetylcholine, membranes, and circulation. Most major ingredients reach practical standalone amounts.

Branded citicoline and sunflower phosphatidylserine strengthen form quality, while ginkgo and gotu kola lack complete marker percentages. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Acetyl L-Carnitine Supportive 20 studies
Deanol No effect 2 studies
Ginkgo Supportive 87 studies
Productivity Boost
Productivity Boost
Impact
Highest effect
A Goal FitA- Strength of SupportA- CoverageA- Formula Quality
Acetyl L-Carnitine · 500 mgAcetyl L-Carnitine · 500 mg

Acetyl L-carnitine, branded citicoline, phosphatidylserine, and Ginkgo address cognitive energy, neurotransmitter support, cell membranes, and circulation. The main actives are present at meaningful amounts.

The broad stack is logically designed, although DMAE and gotu kola add less certain value. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Acetyl L-Carnitine Supportive 1 study
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Anti-Aging
Anti-Aging
Impact
Highest effect
B+ Goal FitA- Strength of SupportB+ CoverageB+ Formula Quality

Acetyl L-carnitine, citicoline, phosphatidylserine, ginkgo, and gotu kola target mitochondrial energy, cell membranes, and cognitive function. Most amounts are substantial, and several branded or standardized forms improve confidence in the brain-focused design.

DMAE and gotu kola have less convincing evidence for age-related cognitive outcomes, so not every component contributes equally. Ginkgo may increase bleeding risk for people using anticoagulant or antiplatelet medicines, including warfarin, apixaban, or clopidogrel.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Energy
Energy
Impact
Highest effect
B+ Goal FitB+ Strength of SupportB CoverageB Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl L-carnitine supports mitochondrial fuel use, while citicoline and phosphatidylserine add a focused cognitive-energy pathway. The main actives are disclosed at meaningful amounts, making the formula more than a lightly dosed focus blend.

DMAE, ginkgo, and gotu kola create a crowded cognitive stack with less consistent evidence, and duplicate-looking botanical entries reduce clarity. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines such as warfarin, apixaban, or clopidogrel.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Metabolism Boost
Metabolism Boost
Impact
High effect
B Goal FitA- Strength of SupportC+ CoverageB Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl L-carnitine directly supports mitochondrial transport, while citicoline and phosphatidylserine add cellular-energy context. The 500 mg carnitine amount reaches the effective range.

Most companion actives are meaningful, but the formula is primarily organized around cognitive support rather than broad metabolism. Ginkgo extract may raise bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Acetyl L-Carnitine Adverse 1 study

Ingredients

IngredientAmount per serving
Acetyl L-Carnitine
500 mg
Cognizin (Cytidine 5-Diphosphocholine)
 200 mg
DMAE
100 mg
Phosphatidylserine (Sunflower)
 100 mg
Ginkgo Biloba leaf extract (Ginkgoflavonglycosides, Terpene Lactones)
 120 mg
Gotu Kola herb extract (Asiaticoside, triterpenes)
 100 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
Acetyl L-Carnitine · 500 mg OverallScore76
B Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The disclosed Acetyl L-Carnitine amount reaches the standard range for cognitive and metabolic support. Cognizin citicoline and phosphatidylserine add meaningful ingredients, though the unspecified ALCAR salt and absent purity details limit confidence in sourcing. Ginkgo extract may raise bleeding risk for people using anticoagulant or antiplatelet medicines.

View ingredientView products
Ginkgo (Ginkgoflavonglycosides, Terpene Lactones) · 120 mg OverallScore52
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

The formula provides a practical ginkgo amount alongside several cognitive-support ingredients, but active-marker percentages are absent. No ginkgolic acid purity limit or recognized purified extract is disclosed, and the serving carries a high cost. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

View ingredientView products
Deanol · 100 mg OverallScore42
F Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyF Value

The listed DMAE amount fits a commonly used supplemental range and requires only two capsules. The label does not identify the salt form or clarify active DMAE yield, which limits dose confidence. No Deanol-specific caution is provided, and the cost is high for the disclosed DMAE content.

View ingredientView products
Loading alternative details
75 Performance

Memoractiv

Thorne
<p>Branded ginkgo phytosome, ashwagandha, acetyl-L-carnitine, carotenoids, and caffeine create a well-specified cognitive and stress formula. It drops DMAE and citicoline but adds stronger vision and stress pathways, with high serving cost as the main trade-off.</p>
76 Performance

Ultimate Neuro Complex

Natural Factors 3 Brains
<p>Acetyl-L-carnitine, N-acetyl cysteine, alpha-lipoic acid, and huperzine provide strong cellular-energy and cognitive depth. Ginkgo is modest and vinpocetine plus huperzine add interaction concerns, but the formula offers broader anti-aging and productivity support.</p>
68 Performance

Memory Pro

Pure Encapsulations
<p>Acetyl-L-carnitine, well-specified ginkgo, bacopa, turmeric, and carotenoids create a thoughtful cognitive and antioxidant blend. Several supporting amounts are modest and value is weak, but the ingredient forms and vision pathway are stronger than in the original.</p>
74 Budget

True Focus

NOW
<p>Tyrosine, phenylalanine, DMAE, grape-seed extract, and ginkgo create a plausible focus formula at a fraction of the recurring cost. It lacks the original acetyl-L-carnitine and citicoline depth, and phenylalanine is unsuitable for people with phenylketonuria.</p>
63 Budget

Ginkgo Smart

Irwin Naturals
<p>Standardized ginkgo, DMAE, and fish oil preserve several cognitive pathways at a much lower serving cost. Most secondary actives are modest and omega-fat details are missing, but the formula offers a closer ingredient match than many low-cost options.</p>
61 Budget

Brain Essentials

Swanson
<p>Ginkgo and DMAE retain two original collections in a very economical broad cognitive formula. DHA, phosphatidylserine, amino acids, and other actives are shallow, so value improves more than dose quality.</p>
72 Value

NeuroIGNITE

Havasu Nutrition
<p>Bacopa, ginkgo, DMAE, acetyl-L-carnitine, and phosphatidylserine provide broad overlap at much lower recurring cost. Several amounts are light, and St. John’s wort creates extensive medication interactions, so the value advantage only applies when those risks are not relevant.</p>
68 Value

Boost

NaturesPlus BrainCeutix
<p>Phosphatidylserine, acetyl-L-carnitine, bacopa, ginkgo, and huperzine offer broad cognitive coverage for less per serving. Some headline doses are modest and duplicate entries blur the label, but the quality-to-cost balance improves over the original premium formula.</p>
62 Value

Ginkgo Smart

Irwin Naturals
<p>Standardized ginkgo, fish oil, DMAE, and acetyl-L-carnitine create a familiar cognitive pattern at strong serving value. EPA, DHA, and the clubmoss active are not quantified, but the formula retains more of the original ingredient logic than simpler alternatives.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  2. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledCognitive Support forGinkgo
  3. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  4. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsCognitive Support Brain Health forAcetyl L-Carnitine
  5. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsCognitive Support Brain Health forAcetyl L-Carnitine
  6. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.
    Thal LJ; Calvani M; Amato A; Carta A · Neurology · 2000
    Randomized trial229 participantsCognitive Support forAcetyl L-Carnitine
  7. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach.
    Brooks JO; Yesavage JA; Carta A; Bravi D · International psychogeriatrics · 1998
    Randomized trial334 participantsCognitive Support forAcetyl L-Carnitine
  8. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
    Malaguarnera G; Catania VE; Bertino G; Chisari LM; Castorina M; Bonfiglio C; Cauli O; Malaguarnera M · Current pharmaceutical design · 2022
    Randomized trial92 participantsAnti-Aging forAcetyl L-Carnitine
  9. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  10. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  11. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  12. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  13. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  14. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  15. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  16. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  17. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  18. Senile dementia: treatment with deanol.
    Ferris SH; Sathananthan G; Gershon S; Clark C · Journal of the American Geriatrics Society · 1977
    Single-arm trial14 participantsCognitive Support forDeanol
  19. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies.
    Blin O; Audebert C; Pitel S; Kaladjian A; Casse-Perrot C; Zaim M; Micallef J; Tisne-Versailles J; Sokoloff P; Chopin P; Marien M · Psychopharmacology · 2010
    Randomized trial24 participantsCognitive Support forDeanol
  20. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  21. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  22. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  23. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  24. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsEnergy forAcetyl L-Carnitine
  25. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
    Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Randomized trial60 participantsEnergy forAcetyl L-Carnitine
  26. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G · Scandinavian journal of gastroenterology · 2011
    Randomized trial67 participantsEnergy forAcetyl L-Carnitine
  27. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y · Experimental and therapeutic medicine · 2020
    Randomized trial239 participantsEnergy forAcetyl L-Carnitine
  28. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
    Kumar R; Nuñez NA; Joshi N; Joseph B; Verde A; Seshadri A; Cuellar Barboza AB; Prokop LJ; Medeiros GC; Singh B · Bipolar disorders · 2024
    Systematic reviewEnergy forAcetyl L-Carnitine
  29. Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
    Malaguarnera G; Pennisi M; Gagliano C; Vacante M; Malaguarnera M; Salomone S; Drago F; Bertino G; Caraci F; Nunnari G; Malaguarnera M · Hepatitis monthly · 2014
    Randomized trial62 participantsMental Focus Productivity Boost forAcetyl L-Carnitine
  30. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
    Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B · La Clinica terapeutica · 1992
    Non-randomized trial17 participantsMental Focus forAcetyl L-Carnitine
  31. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
    Arnold LE; Amato A; Bozzolo H; Hollway J; Cook A; Ramadan Y; Crowl L; Zhang D; Thompson S; Testa G; Kliewer V; Wigal T; McBurnett K; Manos M · Journal of child and adolescent psychopharmacology · 2008
    Randomized trial112 participantsMental Focus forAcetyl L-Carnitine
  32. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE · The Cochrane database of systematic reviews · 2019
    Meta-analysis398 participants5 studies pooledMental Focus forAcetyl L-Carnitine
  33. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  34. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  35. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  36. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  37. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  38. Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism.
    Krims-Davis K; Ozola M; Razzivina V; Gukalova B; Konrade I; Dambrova M; Liepinsh E · Molecular nutrition & food research · 2025
    Randomized trialMetabolism Boost forAcetyl L-Carnitine
  39. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  40. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  41. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  42. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  43. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo